Breast cancer is the most common malignancy in women in the United States and the developed world.
1,2 Approximately 5% to 10% of women diagnosed as having breast cancer present with stage IV disease and have an intact primary breast tumor.
3 While this represents a small portion of patients with breast cancer, given the prevalence of the disease, management of the primary tumor in stage IV disease remains a common clinical scenario. As with earlier-stage disease, these tumors are heterogeneous with regard to biology and disease burden. The appropriate local management of the primary tumor in stage IV breast cancer, which currently is largely considered incurable, continues to be debated.